LOGIN  |  REGISTER

Waters (NYSE: WAT) Stock Quote

Last Trade: US$294.94 -0.57 -0.19
Volume: 234,591
5-Day Change: -1.87%
YTD Change: -10.42%
Market Cap: US$17.500B

Latest News From Waters

HealthStocksHub
News Summary: Waters Xevo™ MRT Mass Spectrometer employs next-generation multi-reflecting time-of-flight technology to deliver class-leading combination of high resolution and speed without compromising analytical performance. i Delivers up to 6x resolution at maximum speed and up to 2x mass accuracy of competitive systems, ii... Read More
HealthStocksHub
News Summary: Waters becomes the first vendor to obtain ACT™ Ecolabel Certification for 42 of its liquid chromatography columns, providing independent validation of the environmental impact of Waters column manufacturing, use, packaging, and disposal. Laboratory products that earn the ACT Environmental Impact Factor label make... Read More
MILFORD, Mass. , May 13, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra Ph.D., Waters President and Chief Executive Officer, will participate in a fireside chat at the Jefferies 2024 Healthcare Conference on Wednesday, June 5th, 2024 at 9:30AM Eastern Time . A live webcast of the event will be available on the 'Events & Presentations' section of Waters Investor Relations website at... Read More
HealthStocksHub
VANCOUVER, BC , May 13, 2024 /PRNewswire/ -- WAT Medical, a leader in innovative healthcare solutions, announces the development of ObeEnd, the world's first weight management wristband backed by clinical evidence showcasing its efficacy in reducing dietary intake. Findings from this groundbreaking study were presented at the... Read More
HealthStocksHub
News Summary: ACQUITY™ QDa™ II Mass Detector enhances confidence in routine compound identification using the specificity of mass analysis to boost efficiency, robustness, and productivity in LC-UV separations, while leveraging the Empower™ Chromatography Data System for complete traceability. Provides a 20% enhancement in... Read More
Highlights Sales of $637 million at the high-end of guidance, declined 7% as reported and 9% in organic constant currency GAAP EPS of $1.72 ; earnings well above guidance, with non-GAAP EPS of $2.21 Operational excellence drove gross margin expansion of 40 basis points and adjusted operating margin expansion of 20 basis points Strong operating cash flow generation at $263 million ; free cash flow of $234 million was 37% of... Read More
HealthStocksHub
News Summary: New line of GTxResolve™ Premier SEC Columns provide higher sensitivity, resolution, and throughput to accelerate the development of cell & gene-based therapeutics. Reduces problematic non-specific binding, minimizes mobile phase method development challenges, and provides higher throughput separation efficiency.... Read More
MILFORD, Mass. , April 11, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q1 2024 financial results conference call live on Tuesday, May 7th , 2024 at 8:00 a.m. Eastern Time . A live webcast of the presentation will be available on Waters Investor Relations website at h ttps://ir.waters.com . A replay of the webcast will also be available until at least June 4th, 2024 , at midnight Eastern Time . About... Read More
HealthStocksHub
News Summary: New Alliance™ iS Bio High Performance Liquid Chromatography (HPLC) System helps biopharmaceutical QC laboratories boost efficiency and eliminate up to 40% of common errors i . Featuring MaxPeak™ High Performance Surface (HPS) Technology, the new system minimizes unwanted analyte interactions to increase... Read More
HealthStocksHub
News Summary: Waters Oasis™ Dual-phase PFAS Analysis Cartridges simplify sample preparation for EPA 1633 testing for analysis of PFAS concentrations in non-potable water, soils, biosolids, and tissue. Reduces sample preparation time by 20% and sample processing time by approximately 30 minutes per batch to boost sample... Read More
HealthStocksHub
News Summary: Waters now enables seamless connectivity between its liquid chromatography (LC) systems and multi-angle light-scattering instruments (MALS) for improved ease-of-use, efficiency, and data confidence in characterizing large molecules. HPLC CONNECT™ software accelerates precise characterization of complex molecules... Read More
MILFORD, Mass. , Feb. 22, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the TD Cowen 44th Annual Health Care Conference on Monday, March 4th, 2024 at 11:10AM Eastern Time A live webcast of the event will be available on the 'Events & Presentations' section of Waters Investor Relations website at... Read More
Highlights Fourth Quarter 2023 Sales of $819 million declined 4.5% as reported and 8% in organic constant currency, in line with guidance Operational excellence drove gross margin expansion of 170 basis points and adjusted operating margin expansion of 120 basis points Non-GAAP EPS of $3.62 at the high end of guidance; GAAP EPS of $3.65 Full-Year 2023 Strong execution in tough market conditions delivered sales of $2,956... Read More
MILFORD, Mass. , Jan. 18, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q4 2023 financial results conference call live on Tuesday, February 6th , 2024 at 8:00 a.m. Eastern Time . A live webcast of the presentation will be available on Waters Investor Relations website at https://ir.waters.com . A replay of the webcast will also be available until at least March 5th, 2024 , at midnight Eastern Time . About... Read More
MILFORD, Mass. , Dec. 21, 2023 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 8, 2024 at 7:30PM Eastern Time ( 4:30PM Pacific Standard Time (PST)). A live webcast of the event will be available on the 'Events & Presentations'... Read More
News Summary: My Green Lab awards ACT label to the Waters Xevo™ TQ Absolute system, providing independent validation for its sustainable manufacturing, packaging operation, and end-of-life. Laboratory instruments that earn the ACT label make it easy for scientists and procurement professionals to choose more sustainable products. Xevo TQ Absolute system is up to 45% smaller, uses up to 50% less power and nitrogen, and... Read More
MILFORD, Mass. , Dec. 19, 2023 /PRNewswire/ -- Waters Corporation (NYSE: WAT) announced it has been named to the Dow Jones Sustainability North America Index (DJSI North America) for the third consecutive year, based on the strength of its enterprise-wide ESG practices. The DJSI is informed by the S&P Global Corporate Sustainability Assessment (CSA), an annual evaluation of companies' sustainability practices. "We are... Read More
MILFORD, Mass. , Dec. 18, 2023 /PRNewswire/ -- Waters Corporation ( NYSE: WAT) today announced that its Board of Directors has been named 2024 "Public Company Board of the Year" by the National Association of Corporate Directors (NACD) New England Chapter. This award recognizes exceptional corporate knowledge, leadership, and governance of directors in New England Waters Chairman Dr. Flemming Ornskov and Dr. Udit Batra ,... Read More
News Summary: Waters inaugurates Global Capability Center in Bengaluru's RMZ Ecoworld technology park with dignitaries from government, customers, partners, and employees. New US$16M (INR ₹1.3Bn) facility will employ 300+ for roles enabling leading-edge software engineering, technology and product development, data analytics and IT. The Global Capability Center will enable Waters to accelerate technology and software... Read More
HealthStocksHub
News Summary: Waters recognized for its companywide policies and active commitment to LGBTQIA+ workplace equality and inclusion, scoring 100 on the Human Rights Campaign Foundation's 2023-2024 Corporate Equality Index. Top score for second year in a row validates Waters efforts to support all employees through dedicated... Read More
MILFORD, Mass. , Nov. 16, 2023 /PRNewswire/ -- Waters Corporation (NYSE: WAT) announced that Udit Batra Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the Evercore ISI HealthCONx 2023 Health Care Conference in Miami on Thursday, November 30th, 2023 at 8:20AM Eastern Time . A live webcast of the event will be available on the 'Events & Presentations' section of Waters' Investor Relations... Read More
HealthStocksHub
News Summary: Waters makes strong progress on its goal to reduce greenhouse gas emissions 35% by 2025 through greater use of renewable/low-carbon energy sources and further cutting Scope 1 and Scope 2 emissions by 27% over a 2016 baseline. Company-led diversity, equity, and inclusion initiatives contribute to more women in... Read More
Highlights Sales of $712 million grew less than 1% as reported and declined 4% in organic constant currency Low single-digit organic constant currency growth outside of China , led by mid-single-digit pharma growth Wyatt acquisition continued its strong start, adding 4% to sales On a GAAP basis, EPS was $2.27 and operating income margin was 25.2% Non-GAAP EPS grew 8% to $2.84 , as gross margin expanded 240 basis points and... Read More
Jonathan Pratt to Step Down to Pursue an External Opportunity Christos Ross Named Interim Senior Vice President of the Waters Division MILFORD, Mass. , Oct. 24, 2023 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today announced that Jonathan ("Jon") Pratt has decided to step down from his role as Senior Vice President of the Waters Division, to pursue an external opportunity. He will remain with Waters until October 27, 2023... Read More
HealthStocksHub
News Summary: Delivers up to 2x [i] higher oligonucleotide recovery from biofluids with improved LC-MS sensitivity and reproducibility to support robust quantitation. Faster time-to-results for expanded range of bioanalysis projects enabled through enhanced LC-MS sensitivity, and standardized protocols that reduce method... Read More
MILFORD, Mass. , Oct. 10, 2023 /PRNewswire/ -- Waters Corporation (NYSE: WAT) will hold its Q3 2023 financial results conference call live on Tuesday, November 7th , 2023 at 8:00 a.m. Eastern Time . A live webcast of the presentation will be available on Waters' Investor Relations website at https://ir.waters.com . A replay of the webcast will also be available until at least November 21, 2023 , at midnight Eastern Time.... Read More
HealthStocksHub
News Summary: New Zeta Star™ instrument for nanoparticle analysis from Wyatt Technology™ portfolio combines three light scattering techniques into a single device – cutting measurement time by up to 10x[i] over other methods. Measures biologic drug products at extremely low sample volumes to determine five critical parameters... Read More
HealthStocksHub
News Summary: Updated Waters™ OneLab™ software creates new, easy-to-use walk-up solutions integrating Waters BioAccord™ LC-MS system and Andrew+™ robot with upstream bioreactors to automate routine product quality and cell culture media analyses. New pre-developed LC-MS analytical workflows make it even easier for bioprocess... Read More
MILFORD, Mass. , Aug. 30, 2023 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the Bank of America Global Healthcare Conference in London on Wednesday, September 13th, 2023 at 8:20AM Eastern Time ( 1:20PM British Summer Time (BST)). A live webcast of the event will be available on the 'Events & Presentations' section... Read More
Highlights Sales of $741 million grew 4% as reported and 3% in organic constant currency Strength led by double-digit growth in Industrial and Academic & Government Operational excellence added 230 basis points of gross margin expansion High single-digit organic constant currency growth in the U.S. and Europe was partially offset by Pharma weakness in China Wyatt acquisition ahead of expectations with 2% sales contribution... Read More
HealthStocksHub
News Summary: Reduces the cost of gene therapies by using 3-10x less sample than other methods i while generating faster results and more drug substance information. XBridge Premier GTx BEH SEC columns and a new multi-attribute quantification method doubles analytical speed, quadruples sensitivity, and increases resolution of... Read More
MILFORD, Mass. , July 5, 2023 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q2 2023 financial results conference call live on Wednesday, August 2 nd , 2023, at 8:00 a.m. Eastern Time . A live webcast of the presentation will be available on Waters' Investor Relations website at https://ir.waters.com . A replay of the webcast will also be available until at least August 16 th , 2023, at midnight Eastern Time.... Read More
News Summary: Waters and Princeton University signed a multi-year agreement to take on real-world challenges in biologics and materials research. Initial collaboration will bring together Waters scientists with Princeton faculty and students to advance research in drug discovery and development using novel bioseparation techniques. Additional joint research areas may include higher purity pharmaceuticals, advanced analytical... Read More
MILFORD, Mass. , June 12, 2023 /PRNewswire/ -- U.S. News & World Report , the global authority in rankings and consumer advice, has named Waters Corporation (NYSE:WAT) one of the 2023-2024 Best Companies to Work For. Waters was ranked among 200 companies on factors contributing to job seekers' decision-making when choosing a workplace that best meets their needs. The inaugural list evaluated companies based on how well they... Read More
HealthStocksHub
News Summary: New resolution enhancement mode (REM) for Waters' multi-reflecting time-of-flight (MRT) mass spectrometer leads to greater specificity and higher sample throughput for metabolomics UPLC™-MS/MS and MS imaging studies. Waters' MRT System is the only commercially available instrument capable of 300,000 full width... Read More
HealthStocksHub
News Summary: Waters combines the enhanced desorption electrospray ionization (DESI) source with the Xevo TQ Absolute tandem quadrupole mass spectrometer to enable faster and more sensitive targeted pre-clinical MS imaging experiments. 5X more sensitive and 5X faster than discovery-grade quadrupole time-of-flight MS imaging... Read More
News Summary: Integration of Sartorius' process scale multi-column chromatography with Waters' process analytical technology to provide robust analytical data for downstream biomanufacturing of mAbs, recombinant proteins, vaccines, and other biologics. Integrated solution to deliver vital analytical data in days, not weeks – and to reduce waste and help lower drug production costs. Bioprocess scientists will be able to check... Read More
MILFORD, Mass. , May 23, 2023 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the Jefferies Healthcare Conference in New York City on Thursday, June 8th, 2023 at 9:30AM Eastern Time . A live webcast of the event will be available on the 'Events & Presentations' section of Waters' Investor Relations website at... Read More
HealthStocksHub
MILFORD, Mass. , May 16, 2023 /PRNewswire/ -- Waters™ Corporation (NYSE:WAT) today announced it has completed its acquisition of Wyatt Technology, a pioneer and well-recognized leader in innovative light scattering and field-flow fractionation instruments, software, accessories, and services. With more than 80% of its rapidly... Read More
Highlights First Quarter 2023 First quarter sales of $685 million declined 1% as reported and grew 3% in constant currency Growth in broader Asia and Europe offset by weakness in China and the U.S. Instrument revenues declined 3% in constant currency as Pharma customers recalibrated and delayed spending Recurring revenues grew high-single-digits in constant currency, with continued strength supported by commercial... Read More
HealthStocksHub
News Summary: Waters adds the Xevo TQ Absolute IVD System to its MassTrak IVD portfolio of LC-MS/MS systems, making it the most sensitive benchtop tandem quadrupole (TQ) mass spectrometer for clinical applications. i Provides up to five times the sensitivity of instruments in its class, ii with lower detection limits for... Read More
MILFORD, Mass. / Mar 28, 2023 / Business Wire / Waters™ Corporation (NYSE:WAT) today announced the appointment of Richard Fearon to its Board of Directors, effective March 27, 2023. Mr. Fearon is the former Vice Chairman and Chief Financial and Planning Officer of Eaton Corporation, a multinational power management company. “Rick’s expertise is at the intersection of financial excellence, strategic development and... Read More
PHILADELPHIA / Mar 20, 2023 / Business Wire / PITTCON 2023 – Waters Corporation (NYSE:WAT) today introduced Alliance iS , the next-generation intelligent HPLC System, designed to reduce compliance risk by adding new levels of proactive error detection, troubleshooting and ease-of-use. When combined with Waters’ compliance-ready Empower Chromatography Software and eConnect™ HPLC Columns , the Alliance iS High Performance... Read More
MILFORD, Mass. / Feb 15, 2023 / Business Wire / Waters Corporation (NYSE: WAT) today announced its financial results for the fourth quarter and full-year 2022. Sales for the fourth quarter of 2022 were $859 million, an increase of 3% as reported and 9% in constant currency, compared to sales of $836 million for the fourth quarter of 2021. On a GAAP basis, diluted earnings per share (EPS) for the fourth quarter of 2022... Read More
MILFORD, Mass. / Feb 15, 2023 / Business Wire / Waters Corporation (NYSE:WAT) today announced it has entered into an agreement to acquire Wyatt Technology, a pioneer in innovative light scattering and field-flow fractionation instruments, software, accessories, and services, for $1.36 billion in cash, subject to certain adjustments. The transaction is expected to close in the second quarter of 2023, subject to regulatory... Read More
Waters Corporation (NYSE:WAT) will hold its Q4 2022 financial results conference call live on Wednesday, February 15 th 2023 at 8:00 a.m. eastern time. A live webcast of the presentation will be available on Waters’ investor relations website at https://ir.waters.com . A replay of the webcast will also be available until at least March 1 st , 2023, at midnight eastern time. About Waters Corporation Waters Corporation... Read More
Amneal Pharmaceuticals

COPYRIGHT ©2023 HEALTH STOCKS HUB